11 suspended. 11 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Suspended 11 |
| Phase 2 | 2 | Suspended 2 |
Follow Infections: new trials by email Literature Review of Infections trials Research Report on Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation ivermectin infant formula preparation, Standard ivermectin 3mg tablet - Scabies | Phase 1 | Suspended | Murdoch Childrens Research Institute | 52 | 2027-01-01 | 2026-10-09 |
| The DART DELIVER-02 Study MGD020, MGD014, Vorinostat - HIV (Human Immunodeficiency Virus) | Phase 1 | Suspended | University of North Carolina, Chapel Hill | 24 | 2025-10-02 | 2026-09-22 |
| A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma Brincidofovir - Relapsed or Refractory Lymphoma Including ENKL | Phase 1 / Phase 2 | Suspended | SymBio Pharmaceuticals | 43 | 2025-06-09 | 2026-02-05 |
| Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants VRC01.23LS, PGT121.414.LS, PGDM1400LS - HIV Infections | Phase 1 | Suspended | HIV Vaccine Trials Network | 77 | 2024-08-14 | 2024-07-05 |
| Controlled Human Malaria Infection Transmission Model - Phase A PfSPZ Challenge, Sulfadoxine-Pyrimethamine, Piperaquine - Malaria,Falciparum | Phase 1 / Phase 2 | Suspended | University of Oxford | 44 | 2022-08-22 | 2024-05-23 |
| Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers Rifampicin - Tuberculosis | Phase 1 | Suspended | National University Hospital, Singapore | 18 | 2015-02-01 | 2017-04-13 |
| Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia anti-CD19 redirected NK cells - B-cell Acute Lymphoblastic Leukemia | Phase 1 | Suspended | National University Health System, Singapore | 20 | 2013-09-01 | 2019-04-12 |
| Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT CMV-TCR transduced donor-derived T cells - Haematological Malignancies, CMV Infection | Phase 1 | Suspended | University College, London | 10 | 2013-07-01 | 2018-09-12 |
| Ph1 Study of Valortim and Ciprofloxacin in Humans Ciprofloxacin and Valortim, Placebo Antibiotic and Valortim, Placebo Antibiotic and Placebo Valortim - Anthrax | Phase 1 | Suspended | PharmAthene, Inc. | 26 | 2009-08-01 | 2010-08-10 |
| A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers Sendai virus vaccine - Parainfluenza, Respiratory Viral Infections | Phase 1 | Suspended | St. Jude Children's Research Hospital | 54 | 2005-05-05 | 2026-03-30 |
| BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma BL22 immunotoxin, antibody-drug conjugate therapy, immunotoxin therapy - Leukemia, Lymphoma | Phase 1 | Suspended | MedImmune LLC | 95 | 2004-01-01 | 2007-12-28 |
Burkitt Lymphoma (2) · Lymphoma (2) · Acquired Immunodeficiency Syndrome (1) · Anthrax (1) · Cytomegalovirus Infections (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Epstein-Barr Virus Infections (1) · HIV Infections (1) · Immunoblastic Lymphadenopathy (1) · Leukemia (1) · Leukemia-Lymphoma, Adult T-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, T-Cell (1) · Malaria, Falciparum (1)
Virus Diseases (7) · Immune System Diseases (5) · DNA Virus Infections (4) · Herpesviridae Infections (4) · Hemic and Lymphatic Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma, B-Cell (3) · Lymphoma, Non-Hodgkin (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · RNA Virus Infections (3) · Tumor Virus Infections (3)
Antibodies, Monoclonal (1) · Artemether, Lumefantrine Drug Combination (1) · Ciprofloxacin (1) · Primaquine (1) · RFB4(dsFv)-PE38 recombinant immunotoxin (1) · Rifampin (1) · Sodium Chloride (1) · Tablets (1) · Vorinostat (1) · brincidofovir (1) · fanasil, pyrimethamine drug combination (1) · piperaquine (1)
HIV Vaccine Trials Network (1) · MedImmune LLC (1) · Murdoch Childrens Research Institute (1) · National University Health System, Singapore (1) · National University Hospital, Singapore (1) · PharmAthene, Inc. (1) · St. Jude Children's Research Hospital (1) · SymBio Pharmaceuticals (1) · University College, London (1) · University of North Carolina, Chapel Hill (1) · University of Oxford (1)
United States (4) · Singapore (3) · Kenya (2) · Australia (1) · China (1) · Japan (1) · South Africa (1) · United Kingdom (1)
Alan S. Wayne, MD (1) · Amanda Gwee (1) · Cynthia Gay (1) · Cynthia L. Gay, MD (1) · Dario Campana (1) · Elisabeth Adderson, MD (1) · Emma Morris, Prof (1) · Hans Stauss, Prof (1) · Hyman Scott (1) · Nicholas Paton (1) · Poh Lin Tan (1) · Ralph A. Schutz, M.D. (1)
PMID 28054442, PMID 30655164, PMID 40333329
2008 (1), UM1AI068614 (1)